Perspectives of biotechnology

Kevan M.A. Gartland, Munis Dundar, Tommaso Becari, Mariapia Viola Magni, Jill S. Gartland

    Research output: Contribution to conferenceAbstract

    Abstract

    Biotechnology develops and applies principles and tools for engineering living systems. The biotech sector, forecast to be worth >$415 Bn by 2017, is providing a torrent of new genomic sequence and gene expression data, alongside a plethora of precision medicine and novel bio-pharma drug discovery opportunities including theranostics, innovative stem cell applications and treatments for epidemics. As gene editing methodologies with tools such as CRISPR and TALENS and our understanding of gene drives increases, their use for example in potential control of pathogen intermediate vectors receives scrutiny and the need for gene drive ‘brakes’ is apparent. Issues surrounding the use of genetically modified animal and plants pose societal, as much as technological questions. Additive manufacturing, synthetic biology and enhanced imaging systems such as cryo-electron microscopy, provide further creative challenges for biotechnology. Each of these areas will contribute to biotechnology playing an increasing role in the development of circular bio-economy and sustainable development solutions for the foreseeable future.
    Original languageEnglish
    PagesS4
    Number of pages1
    DOIs
    Publication statusPublished - 20 Jul 2016

    Fingerprint

    biotechnology
    synthetic biology
    genes
    sustainable development
    stem cells
    manufacturing
    medicine
    engineering
    image analysis
    genomics
    drugs
    gene expression
    pathogens
    animals
    methodology
    cryo-electron microscopy

    Keywords

    • biotechnology
    • biotechnology industry
    • biotechnology sector
    • biotech

    Cite this

    Gartland, K. M. A., Dundar, M., Becari, T., Viola Magni, M., & Gartland, J. S. (2016). Perspectives of biotechnology. S4. https://doi.org/10.1016/j.jbiotec.2016.05.040
    Gartland, Kevan M.A. ; Dundar, Munis ; Becari, Tommaso ; Viola Magni, Mariapia ; Gartland, Jill S. / Perspectives of biotechnology. 1 p.
    @conference{21360eec44d34fe68777fa954bd48bad,
    title = "Perspectives of biotechnology",
    abstract = "Biotechnology develops and applies principles and tools for engineering living systems. The biotech sector, forecast to be worth >$415 Bn by 2017, is providing a torrent of new genomic sequence and gene expression data, alongside a plethora of precision medicine and novel bio-pharma drug discovery opportunities including theranostics, innovative stem cell applications and treatments for epidemics. As gene editing methodologies with tools such as CRISPR and TALENS and our understanding of gene drives increases, their use for example in potential control of pathogen intermediate vectors receives scrutiny and the need for gene drive ‘brakes’ is apparent. Issues surrounding the use of genetically modified animal and plants pose societal, as much as technological questions. Additive manufacturing, synthetic biology and enhanced imaging systems such as cryo-electron microscopy, provide further creative challenges for biotechnology. Each of these areas will contribute to biotechnology playing an increasing role in the development of circular bio-economy and sustainable development solutions for the foreseeable future.",
    keywords = "biotechnology, biotechnology industry, biotechnology sector, biotech",
    author = "Gartland, {Kevan M.A.} and Munis Dundar and Tommaso Becari and {Viola Magni}, Mariapia and Gartland, {Jill S.}",
    note = "Changed to conference abstract template 25-8-16 ET",
    year = "2016",
    month = "7",
    day = "20",
    doi = "10.1016/j.jbiotec.2016.05.040",
    language = "English",
    pages = "S4",

    }

    Gartland, KMA, Dundar, M, Becari, T, Viola Magni, M & Gartland, JS 2016, 'Perspectives of biotechnology' pp. S4. https://doi.org/10.1016/j.jbiotec.2016.05.040

    Perspectives of biotechnology. / Gartland, Kevan M.A.; Dundar, Munis; Becari, Tommaso; Viola Magni, Mariapia; Gartland, Jill S.

    2016. S4.

    Research output: Contribution to conferenceAbstract

    TY - CONF

    T1 - Perspectives of biotechnology

    AU - Gartland, Kevan M.A.

    AU - Dundar, Munis

    AU - Becari, Tommaso

    AU - Viola Magni, Mariapia

    AU - Gartland, Jill S.

    N1 - Changed to conference abstract template 25-8-16 ET

    PY - 2016/7/20

    Y1 - 2016/7/20

    N2 - Biotechnology develops and applies principles and tools for engineering living systems. The biotech sector, forecast to be worth >$415 Bn by 2017, is providing a torrent of new genomic sequence and gene expression data, alongside a plethora of precision medicine and novel bio-pharma drug discovery opportunities including theranostics, innovative stem cell applications and treatments for epidemics. As gene editing methodologies with tools such as CRISPR and TALENS and our understanding of gene drives increases, their use for example in potential control of pathogen intermediate vectors receives scrutiny and the need for gene drive ‘brakes’ is apparent. Issues surrounding the use of genetically modified animal and plants pose societal, as much as technological questions. Additive manufacturing, synthetic biology and enhanced imaging systems such as cryo-electron microscopy, provide further creative challenges for biotechnology. Each of these areas will contribute to biotechnology playing an increasing role in the development of circular bio-economy and sustainable development solutions for the foreseeable future.

    AB - Biotechnology develops and applies principles and tools for engineering living systems. The biotech sector, forecast to be worth >$415 Bn by 2017, is providing a torrent of new genomic sequence and gene expression data, alongside a plethora of precision medicine and novel bio-pharma drug discovery opportunities including theranostics, innovative stem cell applications and treatments for epidemics. As gene editing methodologies with tools such as CRISPR and TALENS and our understanding of gene drives increases, their use for example in potential control of pathogen intermediate vectors receives scrutiny and the need for gene drive ‘brakes’ is apparent. Issues surrounding the use of genetically modified animal and plants pose societal, as much as technological questions. Additive manufacturing, synthetic biology and enhanced imaging systems such as cryo-electron microscopy, provide further creative challenges for biotechnology. Each of these areas will contribute to biotechnology playing an increasing role in the development of circular bio-economy and sustainable development solutions for the foreseeable future.

    KW - biotechnology

    KW - biotechnology industry

    KW - biotechnology sector

    KW - biotech

    U2 - 10.1016/j.jbiotec.2016.05.040

    DO - 10.1016/j.jbiotec.2016.05.040

    M3 - Abstract

    SP - S4

    ER -

    Gartland KMA, Dundar M, Becari T, Viola Magni M, Gartland JS. Perspectives of biotechnology. 2016. https://doi.org/10.1016/j.jbiotec.2016.05.040